Zoledronic Acid in Cystic Fibrosis

• Research type

  Research Study

• Full title

  A double blind, placebo controlled trial to ascertain the efficacy and safety of intravenous zoledronic acid in adult patients with cystic fibrosis.

• IRAS ID

  86623

• Contact name

  Charles Haworth

• Sponsor organisation

  Papworth Hospital NHS Foundation Trust

• Eudract number

  2011-004949-40

• ISRCTN Number

  n.a

• Clinicaltrials.gov Identifier

  n.a

• Research summary

  The study is a 12 month phase IV study to test the effect of a single intravenous infusion of zoledronate on bone density in patients with cystic fibrosis.

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  12/EE/0515

• Date of REC Opinion

  14 Jan 2013

• REC opinion

  Further Information Favourable Opinion